Curcumin in Alzheimer's Disease and Depression: Therapeutic Potential and Mechanisms of Action

被引:4
|
作者
Oliveira, Jordan Teixeira [1 ]
Pieniz, Simone [1 ]
机构
[1] Univ Fed Pelotas, Dept Nutr, Pelotas, RS, Brazil
关键词
Curcuma longa; turmeric; polyphenol; BDNF; Dementia; neurological disease; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; OXIDATIVE DAMAGE; MESSENGER-RNA; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; RATS INVOLVEMENT; SMALL-INTESTINE; BDNF LEVELS;
D O I
10.1590/1678-4324-2024220004
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Curcumin is a polyphenol present in Curcuma longa, a root used in Asian cuisine for thousands of years, and it has several medicinal properties, acting as an antioxidant, anti-inflammatory, anticancer, among others. Polyphenols generally have the ability to restore BDNF (Brain Derived Neurotrophic Factor) levels, which is a very important neurotrophin in controlling neuronal development and survival, when they are impaired, offering a therapeutic effect. The aim of this study was to evaluate the effects of curcumin in Alzheimer's disease and Depression, which has as its main pathogenesis the reduction of BDNF levels, monoamine levels, increased oxidative stress, inflammation, beta-amyloid aggregation, Tau protein accumulation and aluminum neurotoxicity, verifying its therapeutic capacity. Therefore, a literature review was performed in the Scholar Google, ScienceDirect, and PubMed databases. The data analyzed demonstrated that curcumin supplementation is able to restore BDNF levels in Alzheimer's disease and depression, in addition to modulating monoamines and reducing oxidative stress, inflammation, beta-amyloid aggregation, Tau protein accumulation and aluminum neurotoxicity, improving their symptoms.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Necroptosis in Alzheimer's disease: Potential therapeutic target
    Richard, Riane
    Mousa, Shaker
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 152
  • [22] L-Norvaline, a new therapeutic agent against Alzheimer's disease
    Polis, Baruh
    Srikanth, Kolluru D.
    Gurevich, Vyacheslav
    Gil-Henn, Hava
    Samson, Abraham O.
    NEURAL REGENERATION RESEARCH, 2019, 14 (09) : 1562 - 1572
  • [23] Pathogenesis of Depression in Alzheimer's Disease
    Zhan, Qingyang
    Kong, Fanyi
    Shao, Shuai
    Zhang, Bo
    Huang, Shuming
    NEUROCHEMICAL RESEARCH, 2024, 49 (03) : 548 - 556
  • [24] Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications
    Altuna, Miren
    Olmedo-Saura, Gonzalo
    Carmona-Iragui, Maria
    Fortea, Juan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [25] Gene therapy in Alzheimer's disease - potential for disease modification
    Nilsson, Per
    Iwata, Nobuhisa
    Muramatsu, Shin-ichi
    Tjernberg, Lars O.
    Winblad, Bengt
    Saido, Takaomi C.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (04) : 741 - 757
  • [26] Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches
    Siddappaji, Kiran Kumar
    Gopal, Shubha
    AIMS NEUROSCIENCE, 2021, 8 (03) : 357 - 389
  • [27] Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease
    Shiveena Bhatia
    Manjinder Singh
    Tanveer Singh
    Varinder Singh
    Neurochemical Research, 2023, 48 : 13 - 25
  • [28] The Therapeutic Potential of Yoga for Alzheimer's Disease: A Critical Review
    Brown, Adriel
    Bayley, Peter J.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S521 - S535
  • [29] Therapeutic potential of lipase inhibitor orlistat in Alzheimer's disease
    Du, Jing
    Wang, Zhao
    MEDICAL HYPOTHESES, 2009, 73 (05) : 662 - 663
  • [30] Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease
    Bhatia, Shiveena
    Singh, Manjinder
    Singh, Tanveer
    Singh, Varinder
    NEUROCHEMICAL RESEARCH, 2023, 48 (01) : 13 - 25